Workflow
胶原产品
icon
Search documents
东宝生物:公司正按计划稳步推进股票回购事项
Group 1 - The core viewpoint of the articles highlights the importance of share buybacks as a value management tool in the capital market, especially following the release of new policies that support stock repurchase initiatives [1] - The company Dongbao Biological Technology Co., Ltd. has actively implemented its share buyback plan, with a total repurchase amount exceeding 40 million RMB as of March 31, 2025 [1] - The share buyback plan aims to optimize incentive systems, enhance innovation culture, and maintain company value and shareholder rights, thereby boosting investor confidence [1] Group 2 - Dongbao Biological is committed to advancing its "Collagen+" strategy to build a premium collagen brand, focusing on extending the industrial chain and enhancing the value chain [2] - The company plans to deepen its development in the health industry through high-quality growth and innovation, while also improving its core competitiveness [2] - The strategic focus includes comprehensive planning across brand, market, innovation, service, investment, and management to solidify its leading position in the collagen industry [2]
东宝生物:积极推进回购股份计划
Zheng Quan Ri Bao Wang· 2025-04-09 10:45
Core Viewpoint - Dongbao Biological is actively promoting its share repurchase plan to enhance employee incentive mechanisms and support its strategic goals in the collagen industry [1][2] Group 1: Share Repurchase Plan - The company approved a share repurchase plan on January 3, intending to use its own and/or raised funds to buy back its A-shares through centralized bidding or other legal methods [1] - The repurchase amount is set between RMB 50 million and RMB 100 million, with a maximum repurchase price of RMB 8.00 per share [1] - As of March 31, the company has repurchased 7.348 million shares, accounting for 1.2379% of the total share capital, with a total transaction amount of RMB 40.1431 million [1] Group 2: Strategic Focus and Goals - Dongbao Biological focuses on the collagen industry, aiming to innovate and deepen the application of collagen across medical, health, food, and beauty sectors [1] - The company plans to create a vertically integrated product strategy, enhancing brand and channel collaboration to diversify and increase revenue [2] - The goal is to become a leading brand in the domestic collagen market and a comprehensive enterprise group in the health industry, emphasizing scale, platform, and brand benefits [2]